Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Businesswire

05:53 EDT 19th August 2018 | BioPortfolio

Here are the most relevant search results for "Businesswire" found in our extensive news archives from over 250 global news sources.

More Information about Businesswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Businesswire for you to read. Along with our medical data and news we also list Businesswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of Businesswire Companies for you to search.

Showing News Articles 1–25 of 19,000+ from Businesswire

Sunday 19th August 2018

Rally Health and Maria Menounos Host “Rally on the Road” Event in Los Angeles to Celebrate Healthy Living

The Rally on the Road summer tour – bringing free, family-friendly events to cities across the United States – culminates in Los Angeles TV/radio personality Maria Menounos and digital health company Rally HealthTM hosted a free, family-friendly event today in the Venice neighborhood of Los Angeles as part of their “Rally on the Road” summer to...

Friday 17th August 2018

ClearDATA Achieves HITRUST CSF® Certification and HITRUST Certification of the NIST Cybersecurity Framework to Manage Risk, Improve Security Posture and Meet Compliance Requirements

HITRUST CSF Certification and HITRUST Certification of the NIST Cybersecurity Framework validates ClearDATA is committed to meeting key regulations and protecting sensitive information. ClearDATA™, a leading security and compliance expert in the healthcare cloud, today announced that ClearDATA Networks, Inc. HealthDATA Cloud Program, HealthDATA Cloud...

KILL ClearDATA Expands HITRUST Certification for Amazon, Microsoft and Google Cloud Platforms

ClearDATA requests that their press release NewsItemId: 20180808005126 (issued August 8, 2018) entitled “ClearDATA Expands HITRUST Certification for Amazon, Microsoft and Google Cloud Platforms” be killed. The release was issued by ClearDATA without prior authorization from HITRUST. A replacement release will be issued later to...

MOLOGEN and ONCOLOGIE: Global assignment and co-development agreement relating to MOLOGEN’s lead compound lefitolimod

Term sheet: Global assignment and co-development agreement for lead compound lefitolimod Substantial potential payments in milestones and in addition royalties – near-term consideration of €23 million Pivotal IMPALA study with lefitolimod would be almost entirely funded The biopharmaceutical company...

Agilent Completes Acquisition of Young In Scientific Co. Ltd. Assets

Agilent Technologies Inc. (NYSE: A) today announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a leading distributor of analytical and scientific instruments in South Korea and a long-time distributor of Agilent instruments and services....

HCA to Present at September Healthcare Conferences

HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences in September 2018. September 5, 2018 at 10:15 a.m. (EDT) at the Baird 2018 Global Healthcare Conference held at the Intercontinental New York Barclay in New York, NY. September 6, 2018 at 10:20 a.m. (EDT) at the Wells Fargo Securities 2018 ...

Mölnlycke Health Care Welcomes United States Senator Susan Collins of Maine to the Brunswick, Maine Manufacturing Facility

Mölnlycke Health Care, a world-leading medical solutions company, welcomed US Senator Susan Collins (ME) to Mölnlycke’s manufacturing facility in Brunswick. During the visit, Senator Collins had the opportunity to meet with employees and also spoke with company leaders about jobs, the economy and healthcare. Mölnlycke employs approximately 20...

Allina Health Names Ann Madden Rice New President of Abbott Northwestern Hospital

Rice comes from University of California, Davis, Medical Center in Sacramento Allina Health is pleased to announced that Ann Madden Rice will become the new president of Abbott Northwestern Hospital. Rice is currently chief executive officer of the University of California, Davis, Medical Center in Sacramento. She will assume her new role in mid-Octobe...

Hunger Issues and Solutions to be the Focus of Roundtable Discussion Hosted by UnitedHealthcare and Share Food Program

Pennsylvania currently in the top half of all states in household food insecurity, according to America’s Health Rankings UnitedHealthcare and Share Food Program: WHAT:   UnitedHealthcare and Share Food Program leaders will join state ...

The American Journal of Managed Care® Spotlights the Essential Role of Pharmacists in Boosting Vaccination Rates

Expert pharmacists offer strategies to help improve the continuous decline in adult vaccination rates A recent publication from The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, addresses the role of community pharmacies in boosting adult

HPI Community Hospital Group, INTEGRIS and USPI to Form Joint Venture to Improve Access to Care in Oklahoma City

HPI Holdings LLC, an operator of hospitals, outpatient centers and clinics in Oklahoma City, INTEGRIS, Oklahoma’s most advanced health care system, and United Surgical Partners International (USPI), a leading provider of ambulatory services in the United States, have entered into an agreement to form a joint venture designed to offer patients and familie...

Caliva Cannabis Products Top California Sales Rankings in Three Categories

Vertically-integrated company has proven statewide reach, competitive pricing and popularity. Caliva, the California premium cannabis brand, has emerged as the leader in the state’s legal cannabis industry across multiple categories, only six weeks into the state’s new, strict regulations. According to recent sales rankings from Headset, ...

AVEO Announces Pricing of $5.7 Million Public Offering of Common Stock

AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that it has priced an underwritten public offering of 2,500,000 shares of common stock at a price to the public of $2.26 per share, the closing price as of yesterday, August 16, 2018, which would result in aggregate gross proceeds of approximately $5.7 million before underwriting discounts. All of t...

Dry Age-Related Macular Degeneration | A Drug Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for dry age-related macular degeneration. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat dry age-related macular degeneration.

Merz Names Kristina Yu-Isenberg, Ph.D., Vice President of Medical Affairs North America

Merz today announced Kristina Yu-Isenberg, Ph.D., M.P.H, R.Ph., has been named Vice President of Medical Affairs North America, effective immediately. Dr. Yu-Isenberg oversees medical affairs in North America and is located in the Merz North America headquarters in Raleigh, North Carolina. This press release features multimedia. View the full release here: ...

Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and ...

Civitas Solutions, Inc. Announces Retirement of Operating Group President

Civitas Solutions, Inc. (NYSE: CIVI) today announced that Redwood Operating Group President David M. Petersen will retire from the Company on September 30, 2018, the last day of the Company’s current fiscal year. Bruce Nardella, Chair of the Board and Chief Executive Officer, stated “On behalf of the Company, its management team and employees, I am ...

Xeris Pharmaceuticals and OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon

Patients enrolling in Phase 1 clinical trial using Xeris’ ready-to-use liquid glucagon formulation as part of a fully integrated, dual-hormone closed-loop system Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible dru...

CEL-SCI Announces That the NYSE American Approves Plan

CEL-SCI Corporation (NYSE American: CVM) announces that the NYSE American (the “Exchange”) has accepted the Company’s plan to bring itself into compliance with the Exchange's continued listing standards. The Company previously received notice from the Exchange on July 12, 2018, indicating the Company is below compliance with Section 1003(a)(...

Navidea Biopharmaceuticals Announces Results of the Annual Shareholder Meeting

Provides Update Related to the Upcoming FDA Meeting to Confirm the Results of the Phase 2 Trial and Detail the Planned Phase 3 Trial for Rheumatoid Arthritis Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or “the Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today...

Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense ...

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer

Opdivo is now the first Immuno-Oncology treatment approved for small cell lung cancer (SCLC) patients who received platinum-based chemotherapy and at least one other line of therapy Approval based on overall response rate and duration of response from the SCLC cohort of the Phase 1/2 CheckMate -032 trial1

Thursday 16th August 2018

Illumina Announces Pricing of Convertible Senior Notes

Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.0% convertible senior notes due 2023 (the “Notes”). The Notes are being offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Illumina has granted the...

AVEO Announces Proposed Offering of Common Stock

AVEO Pharmaceuticals, Inc. (Nasdaq:AVEO) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the ...

Dicerna Strengthens Board of Directors with Two New Appointments

Industry Veterans J. Kevin Buchi and Cynthia Smith Add Key Industry and Commercial Operations Expertise Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the appointments of J. Kevin Buchi, former chief executive officer of Cephalon, In...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks